SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-010063
Filing Date
2020-02-03
Accepted
2020-02-03 21:48:38
Documents
1
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3883
  Complete submission text file 0001104659-20-010063.txt   5258
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY ST., SUITE 300 CAMBRIDGE MA 02139
Business Address
Turka Laurence A. (Reporting) CIK: 0001800952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38586 | Film No.: 20570534